Global TIL Cell Therapy Market Growth (Status and Outlook) 2025-2031

The global TIL Cell Therapy market size is predicted to grow from US$ 138 million in 2025 to US$ 1107 million in 2031; it is expected to grow at a CAGR of 41.5% from 2025 to 2031.

Tumor-infiltrating lymphocyte (TIL) therapy is an innovative new cancer treatment. TIL cell therapy is a type of cellular immunotherapy that can help your immune system kill cancer cells when other treatments have failed.

United States market for TIL Cell Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for TIL Cell Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for TIL Cell Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key TIL Cell Therapy players cover Iovance Biotherapeutics, Achilles Therapeutics (Pipeline), InstilBio (Pipeline), Obsidian (Pipeline), Turnstone (Pipeline), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “TIL Cell Therapy Industry Forecast” looks at past sales and reviews total world TIL Cell Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected TIL Cell Therapy sales for 2025 through 2031. With TIL Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world TIL Cell Therapy industry.

This Insight Report provides a comprehensive analysis of the global TIL Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on TIL Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global TIL Cell Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for TIL Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global TIL Cell Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of TIL Cell Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:
Single TIL Therapy
Combination TIL Therapy

Segmentation by Application:
Melanoma
Non-small Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Iovance Biotherapeutics
Achilles Therapeutics (Pipeline)
InstilBio (Pipeline)
Obsidian (Pipeline)
Turnstone (Pipeline)
Shenzhen Shali Biotechnology (Pipeline)
Cellular Biomedicine Group (Pipeline)
Shanghai Junsai Biotechnology (Pipeline)

Please note: The report will take approximately 2 business days to prepare and deliver.